Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Hyperlipidemia occurs earlier in patients with MS

Publish date:: March 10, 2020

Key clinical point: Onset of hyperlipidemia tends to occur earlier in patients with multiple sclerosis, compared with matched controls.

Major finding: Patients with multiple sclerosis had a 20% increased risk for earlier onset of hyperlipidemia, relative to matched controls. The effect was greater among females (hazard ratio, 1.22) and African Americans (HR, 1.42).

Study details: An analysis of data from 669 patients with multiple sclerosis and 2,676 matched controls.

Disclosures: The researchers had no relevant disclosures.

Citation:

Krill D et al. ACTRIMS Forum 2020, Abstract P085.

This Week's Must Reads

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Study links sleep meds and dementia risk in older adults,

Childhood Hodgkin survivors have neurocognitive impairment,

Obesity, hypoxia predict severity in children with COVID-19,

Long-term safety and efficacy of teriflunomide for relapsing MS,

Must Reads in Multiple Sclerosis

Long-term safety and efficacy of teriflunomide for relapsing MS,

Newer DMTs are more effective than injectable DMTs in pediatric MS,

Neutrophil granulocyte markers may distinguish between demyelinating diseases,

Bacteria may be associated with risk of MS relapse,

Women with MS may have increased subclinical disease activity during pregnancy,